-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Adient, Raises Price Target to $34

Benzinga·07/09/2026 19:24:30
Listen to the news
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and raises the price target from $33 to $34.